Premier Value Regular Strength Chewable Antacid Peppermint
Antacid Tablets · Tablet, Chewable · Oral
Active ingredient
Active ingredient Calcium Carbonate USP 500mg
Purpose
Purpose Antacid
Uses
Uses relieves:
• heartburn
• sour stomach
• acid indigestion
• upset stomach associated with these symptoms
Warnings
Warnings Ask a doctor or pharmacist before use if you are taking a prescription drug. Antacids may interact with certain prescription drugs. When using this product
• do not take more than 15 tablets in 24 hours
• id pregnant do not take more than 10 tablets in 24 hours
• do not use the maximum dosage for more than 2 weeks except under the advice and supervision of a doctor.
Keep out of reach of children
Keep out of Reach of Children
Directions
Directions
• adults and children 12 years of age and over: chew 2-4 tablets completely as symptoms occur, or as directed by a doctor. Do not swallow tablets whole.
• do not take for symptoms that persist for more than 2 weeks unless advised by a doctor.
Inactive ingredients
Inactive ingredients dextrose, flavors, magnesium stearate, maltodextrin, starch, sucralose.
Questions?
Questions or comments? 1-866-467-2748
Label text from the FDA structured product label by Chain Drug Consortium, LLC (revised Oct 25, 2024). Long sections are shortened; the complete label is on DailyMed.
Active ingredients
- Calcium Carbonate in 1 product
Premier Value Regular Strength Chewable Antacid Peppermint NDC products (1)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 68016-665 | Calcium Carbonate 500 mg/1 Tablet, Chewable | Chain Drug Consortium, LLC | OTC MONOGRAPH DRUG |
Frequently asked questions
What is Premier Value Regular Strength Chewable Antacid Peppermint used for?
Uses relieves: • heartburn • sour stomach • acid indigestion • upset stomach associated with these symptoms
Who makes Premier Value Regular Strength Chewable Antacid Peppermint?
Premier Value Regular Strength Chewable Antacid Peppermint is listed by 1 labeler in the FDA NDC directory, including Chain Drug Consortium, LLC.